Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Samuel Sperling, M.D.,Ph.D.

Concepts (179)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Adam Sperling's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Adam Sperling has written about over time.
RNA Polymerase II, 2 publications between 2002 and 2011, average publication date February 2007. Histones, 4 publications between 2008 and 2011, average publication date July 2009. Heterochromatin, 2 publications between 2009 and 2011, average publication date April 2010. Saccharomyces cerevisiae, 4 publications between 2009 and 2011, average publication date September 2010. Saccharomyces cerevisiae Proteins, 4 publications between 2009 and 2011, average publication date September 2010. DNA, Fungal, 2 publications between 2010 and 2011, average publication date February 2011. DNA Topoisomerases, Type I, 1 publications between 2011 and 2011, average publication date July 2011. DNA Topoisomerases, Type II, 1 publications between 2011 and 2011, average publication date July 2011. Precancerous Conditions, 1 publications between 2017 and 2017, average publication date August 2017. Multiple Myeloma, 7 publications between 2014 and 2021, average publication date October 2017. Myelodysplastic Syndromes, 2 publications between 2016 and 2019, average publication date May 2018. Leukemia, Myeloid, Acute, 4 publications between 2016 and 2019, average publication date August 2018. Hematopoiesis, 3 publications between 2016 and 2020, average publication date February 2019. Thalidomide, 1 publications between 2019 and 2019, average publication date April 2019. Hematologic Neoplasms, 2 publications between 2019 and 2020, average publication date August 2019. Neoplasms, Second Primary, 1 publications between 2020 and 2020, average publication date December 2019. Ubiquitin-Protein Ligases, 2 publications between 2019 and 2020, average publication date February 2020. Lymphohistiocytosis, Hemophagocytic, 2 publications between 2020 and 2020, average publication date July 2020. Splenic Neoplasms, 1 publications between 2021 and 2021, average publication date February 2021.

To see the data from this visualization as text, click here.
Sperling's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (179)
Explore
_
Co-Authors (85)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.